STOCK TITAN

Planned sale of 41,997 MRK (NYSE: MRK) shares via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of MRK common stock has filed a notice of proposed sale under Rule 144 for 41,997 shares. The shares have an aggregate market value of $5,023,311.57, and the planned sale date is February 4, 2026 on the NYSE.

The planned transaction would be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired on February 4, 2026 by exercising options under a registered plan, with the purchase price paid in cash on the same date.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the MRK Form 144 filing disclose about planned share sales?

The filing discloses a planned Rule 144 sale of 41,997 MRK common shares. These shares have an aggregate market value of $5,023,311.57 and are expected to be sold on the NYSE on February 4, 2026.

How many MRK shares are outstanding in this Form 144 notice?

The notice states that 2,482,022,536 MRK common shares are outstanding. This figure provides context for the planned sale of 41,997 shares, showing the overall size of the company’s equity base relative to the proposed transaction.

How were the MRK shares in this Rule 144 filing acquired?

The shares were acquired on February 4, 2026 through the exercise of options under a registered plan. The filer paid for 41,997 shares in cash on the same date before planning the Rule 144 sale.

Which broker is handling the planned MRK share sale under Rule 144?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the intended trading venue is the NYSE.

What is the aggregate market value of MRK shares in this Form 144?

The filing reports an aggregate market value of $5,023,311.57 for the 41,997 MRK common shares to be sold. This value reflects the market price used in the notice for the proposed Rule 144 transaction.

Does the MRK Rule 144 filer make any representation about undisclosed information?

Yes. By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about MRK’s current or prospective operations that has not been publicly disclosed.
Merck & Co

NYSE:MRK

MRK Rankings

MRK Latest News

MRK Latest SEC Filings

MRK Stock Data

287.52B
2.48B
0.07%
80.59%
0.95%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
RAHWAY